| 股票代码 | 603301 | 当期评分 | ||||
| 股票名称 | 振德医疗 | |||||
| 报告日期 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | -- | -- | 0.2025 | 1.4126 | 12.6042 | ✔ |
| 销售净利润率(%) | 8.0088 | 9.3471 | 9.0897 | 9.4545 | 29.6917 | ✔ |
| 销售毛利率(%) | 30.3082 | 28.4479 | 30.2304 | 31.3903 | 46.236 | ✔ |
| 净资产收益率(%) | 18.94 | 21.77 | 11.59 | 11.55 | 58.85 | ✔ |
| 营业增长率(%) | 1.3601 | 26.2386 | 9.37 | 30.7149 | 531.5177 | ✔ |
| 净利润增长率(%) | 4.5845 | 47.3344 | 6.3583 | 35.961 | 2215.8548 | ✔ |
| 每股收益(%) | 1.11 | 1.62 | 1.42 | 1.12 | 10.53 | ✔ |
| 现金流量比率(%) | 22.7588 | 27.4981 | 2.9786 | 24.7726 | 128.3317 | ✔ |
| 三项费用比重(%) | 22.344 | 20.1982 | 17.6763 | 20.4616 | 8.3342 | ✔ |
| 每股净资产(¥) | 5.8327 | 7.4565 | 11.2372 | 9.7056 | 16.803 | ✔ |
| 流动比率(%) | 0.8123 | 0.8687 | 1.5188 | 1.9973 | 2.2203 | ✔ |
| 速动比率(%) | 0.4656 | 0.5557 | 0.9651 | 1.4575 | 1.799 | ✔ |
| 现金比率(%) | 10.4242 | 17.2507 | 44.4859 | 80.9519 | 80.9519 | ✔ |
| 总资产利润率(%) | 6.8988 | 10.0845 | 8.2624 | 7.8149 | 53.3969 | ✔ |
| 主营利润比重% | 314.81 | 252.2108 | 285.007 | 294.2653 | 129.4427 | ✔ |
| 应收账款(万元) | 17,751.77 | 18,926.93 | 26,713.46 | 37,297.34 | 78,147.70 | ✘ |
| 应收票据(万元) | -- | -- | 415.84 | 95.06 | -- | ✘ |
| 预付款项(万元) | 2,007.48 | 3,268.71 | 2,448.07 | 4,839.71 | 31,404.36 | ✔ |
| 存货(万元) | 21,108.43 | 20,760.65 | 37,632.76 | 43,094.11 | 87,781.50 | ✘ |
| 在建工程(万元) | 1,166.22 | 5,575.31 | 13,993.23 | 23,610.18 | 61,072.85 | ✔ |
| 应付款项(万元) | 11,645.01 | 13,402.20 | 18,935.35 | 18,706.54 | 55,762.03 | ✔ |
| 长期借款(万元) | -- | -- | -- | 10,014.62 | 10,011.25 | ✔ |
| 未分配利润(万元) | 6,748.66 | 18,178.75 | 30,592.12 | 41,991.59 | 245,746.92 | ✘ |
| 商誉(万元) | 1,495.12 | 1,495.12 | 3,195.96 | 8,961.57 | 12,750.13 | ✔ |
| 流动资产(万元) | 63,332.82 | 71,781.08 | 81,760.99 | 107,473.38 | 173,146.59 | ✘ |
| 流动负债(万元) | 60,888.25 | 66,311.38 | 67,970.47 | 79,831.10 | 208,345.35 | ✔ |
振德医疗603301评分结果 | 81.82分 | 买入/增持 | ||||